Brief: Genscript Biotech Expects Profit Before Tax Of $175.4M-$204.6M In HY
July 22 (Reuters) - Genscript Biotech Corp 1548.HK: EXPECTS PROFIT BEFORE TAX OF $175.4M-$204.6M IN HY EXPECTS LICENSE REVENUE OF $182.2M-$212.5M IN HY Further company coverage: 1548.HK ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Genscript Biotech
See all newsBrief: Genscript Launches Life Sciences Startup Pitchfest With Nvidia For Biotech Innovation
GenScript Biotech extends gain to hit near 5-year peak on Eli Lilly deal
GenScript Biotech hits near 5-year high on Eli Lilly collaboration
Brief: ProBio & Kun Tuo Announce Strategic Collaboration To Deliver Integrated CDMO-CRO Solutions
HK-listed GenScript Biotech drops on discounted share sale